Figures & data
Figure 1 Regional distribution of respondents according to mental health settings where the respondents performed professional activities.
![Figure 1 Regional distribution of respondents according to mental health settings where the respondents performed professional activities.](/cms/asset/50706490-c957-4a45-8526-5dec1777dab3/dndt_a_96214_f0001_b.jpg)
Table 1 Characteristics of the overall population of survey respondents
Figure 2 Suggested parameters to be considered when evaluating the success of an antipsychotic therapy in patients with schizophrenia.
![Figure 2 Suggested parameters to be considered when evaluating the success of an antipsychotic therapy in patients with schizophrenia.](/cms/asset/13d4392e-33d5-4834-bcef-848ca9b95766/dndt_a_96214_f0002_b.jpg)
Figure 3 Domains of importance of preset responses when assessing treatment success rated from 1 (not important) to 7 (of utmost importance) by psychiatrists treating patients suffering from schizophrenia.
![Figure 3 Domains of importance of preset responses when assessing treatment success rated from 1 (not important) to 7 (of utmost importance) by psychiatrists treating patients suffering from schizophrenia.](/cms/asset/e648037e-d308-4d03-a00f-400de5776e39/dndt_a_96214_f0003_b.jpg)
Figure 4 Psychiatrists’ understanding of quality of life (QoL) in patients with schizophrenia.
![Figure 4 Psychiatrists’ understanding of quality of life (QoL) in patients with schizophrenia.](/cms/asset/dd48ce81-7a06-48f6-89ec-7330d6a82652/dndt_a_96214_f0004_b.jpg)
Figure 5 Importance of preset items when reporting understanding of quality of life (QoL) according to psychiatrists, rated from 1 (not important) to 7 (of utmost importance).
![Figure 5 Importance of preset items when reporting understanding of quality of life (QoL) according to psychiatrists, rated from 1 (not important) to 7 (of utmost importance).](/cms/asset/1753cd28-4fcb-4cbf-8f24-53c1b26a8461/dndt_a_96214_f0005_b.jpg)
Figure 6 Level of importance of preset clinical outcomes when assessing the success of long-acting injectable treatment, rated from 1 (not important) to 7 (of utmost importance) according to psychiatrists treating patients with schizophrenia.
![Figure 6 Level of importance of preset clinical outcomes when assessing the success of long-acting injectable treatment, rated from 1 (not important) to 7 (of utmost importance) according to psychiatrists treating patients with schizophrenia.](/cms/asset/f23dbfe8-d806-432d-a921-fc28c1aa4bff/dndt_a_96214_f0006_b.jpg)
Figure 7 Level of agreement with prescribing long-acting injectable antipsychotic treatment to five preset patient types, rated from 1 (no agreement) to 7 (complete agreement) according to psychiatrists treating patients with schizophrenia.
![Figure 7 Level of agreement with prescribing long-acting injectable antipsychotic treatment to five preset patient types, rated from 1 (no agreement) to 7 (complete agreement) according to psychiatrists treating patients with schizophrenia.](/cms/asset/dbf8c3eb-9d79-4a19-96d1-b4e7ab8d832a/dndt_a_96214_f0007_b.jpg)